Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Elevated TSH in a Thyroidectomized Patient: Differential Diagnosis Beyond Noncompliance with Treatment.

Oliveira JM, Alves TG, Camacho CP, Vieira JGH, Martins JRM.

J Appl Lab Med. 2019 Mar;3(5):903-908. doi: 10.1373/jalm.2018.026542. Epub 2018 Jun 20. No abstract available.

PMID:
31639765
2.

Subclinical Thyroid Dysfunction was not Associated with Cardiac Arrhythmias in a Cross-Sectional Analysis of the ELSA-Brasil Study.

Rajão KMAB, Ribeiro ALP, Passos VMA, Benseñor IJM, Vidigal PG, Camacho CP, Diniz MFHS.

Arq Bras Cardiol. 2019 Jun;112(6):758-766. doi: 10.5935/abc.20190037. Epub 2019 Feb 28. English, Portuguese.

3.

Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study.

Maciel RMB, Camacho CP, Assumpção LVM, Bufalo NE, Carvalho AL, de Carvalho GA, Castroneves LA, de Castro FM Jr, Ceolin L, Cerutti JM, Corbo R, Ferraz TMBL, Ferreira CV, França MIC, Galvão HCR, Germano-Neto F, Graf H, Jorge AAL, Kunii IS, Lauria MW, Leal VLG, Lindsey SC, Lourenço DM Jr, Maciel LMZ, Magalhães PKR, Martins JRM, Martins-Costa MC, Mazeto GMFS, Impellizzeri AI, Nogueira CR, Palmero EI, Pessoa CHCN, Prada B, Siqueira DR, Sousa MSA, Toledo RA, Valente FOF, Vaisman F, Ward LS, Weber SS, Weiss RV, Yang JH, Dias-da-Silva MR, Hoff AO, Toledo SPA, Maia AL.

Endocr Connect. 2019 Mar 1;8(3):289-298. doi: 10.1530/EC-18-0506.

4.

A pioneering RET genetic screening study in the State of Ceará, Brazil, evaluating patients with medullary thyroid cancer and at-risk relatives: experience with 247 individuals.

Martins-Costa MC, Lindsey SC, Cunha LL, Carreiro-Filho FP, Cortez AP, Holanda ME, Farias JWM, Lima SB, Ferreira LAA, Maia Filho PC, Camacho CP, Furuzawa GK, Kunii IS, Dias-da-Silva MR, Martins JRM, Maciel RMB.

Arch Endocrinol Metab. 2018;62(6):623-635. doi: 10.20945/2359-3997000000088.

5.

Assessing the clinical and molecular diagnosis of inherited forms of impaired sensitivity to thyroid hormone from a single tertiary center.

Ramos LS, Kizys MML, Kunii IS, Spinola-Castro AM, Nesi-França S, Guerra RA, Camacho CP, Martins JRM, Maciel RMB, Dias-da-Silva MR, Chiamolera MI.

Endocrine. 2018 Dec;62(3):628-638. doi: 10.1007/s12020-018-1673-6. Epub 2018 Jul 19.

PMID:
30027432
6.

Bethesda Classification and Cytohistological Correlation of Thyroid Nodules in a Brazilian Thyroid Disease Center.

Reuters KB, Mamone MCOC, Ikejiri ES, Camacho CP, Nakabashi CCD, Janovsky CCPS, Yang JH, Andreoni DM, Padovani R, Maciel RMB, Vanderlei FAB, Biscolla RPM.

Eur Thyroid J. 2018 Jun;7(3):133-138. doi: 10.1159/000488104. Epub 2018 Apr 27.

7.

Penetrance of phaeochromocytoma in RET G533C carriers differs between South America and Europe.

Maciel RMB, Bim LV, Camacho CP, Cerutti JM.

Endocr Relat Cancer. 2018 Sep;25(9):L49-L51. doi: 10.1530/ERC-17-0349. No abstract available.

PMID:
30012587
8.

Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors.

Câmara-de-Souza AB, Toyoshima MTK, Giannella ML, Freire DS, Camacho CP, Lourenço DM Jr, Rocha MS, Bacchella T, Jureidini R, Machado MCC, Almeida MQ, Pereira MAA.

Pancreatology. 2018 Apr;18(3):298-303. doi: 10.1016/j.pan.2018.01.009. Epub 2018 Feb 1.

PMID:
29452754
9.

Two Thyroid Stimulating Hormone assays correlated in clinical practice show disagreement in subclinical hypothyroidism patients.

da Silva VA, de Almeida RJ, Cavalcante MP, Pereira Junior LA, Reis FM, Pereira MF, Kasamatsu TS, Camacho CP.

Clin Biochem. 2018 Mar;53:13-18. doi: 10.1016/j.clinbiochem.2017.12.005. Epub 2017 Dec 15.

PMID:
29253509
10.

Clinical utility of 18F-FDG PET/CT in the follow-up of a large cohort of patients with high-risk differentiated thyroid carcinoma.

Yang JH, Maciel RMB, Nakabashi CCD, Janovsky CCPS, Padovani RP, Macellaro D, Camacho CP, Osawa A, Wagner J, Biscolla RPM.

Arch Endocrinol Metab. 2017 Sept-Oct;61(5):416-425. doi: 10.1590/2359-3997000000285. Epub 2017 Sep 18.

11.

Indoleamine 2, 3-dioxygenase (IDO) increases during renal fibrogenesis and its inhibition potentiates TGF-β 1-induced epithelial to mesenchymal transition.

Matheus LHG, Simão GM, Amaral TA, Brito RBO, Malta CS, Matos YST, Santana AC, Rodrigues GGC, Albejante MC, Bach EE, Dalboni MA, Camacho CP, Dellê H.

BMC Nephrol. 2017 Sep 6;18(1):287. doi: 10.1186/s12882-017-0702-7.

12.

THE COMBINED USE OF CALCITONIN DOUBLING TIME AND 18F-FDG PET/CT IMPROVES PROGNOSTIC VALUES IN MEDULLARY THYROID CARCINOMA: THE CLINICAL UTILITY OF 18F-FDG PET/CT.

Yang JH, Camacho CP, Lindsey SC, Valente FOF, Andreoni DM, Yamaga LY, Wagner J, Biscolla RPM, Maciel RMB.

Endocr Pract. 2017 Aug;23(8):942-948. doi: 10.4158/EP171806.OR. Epub 2017 Jun 14.

PMID:
28614009
13.

68Ga-DOTATATE PET/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with 111In-octreotide SPECT/CT and conventional imaging.

Yamaga LYI, Cunha ML, Campos Neto GC, Garcia MRT, Yang JH, Camacho CP, Wagner J, Funari MBG.

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1695-1701. doi: 10.1007/s00259-017-3701-9. Epub 2017 Apr 20.

PMID:
28429044
14.

Clinical impact of thyroglobulin (Tg) and Tg autoantibody (TgAb) measurements in needle washouts of neck lymph node biopsies in the management of patients with papillary thyroid carcinoma.

Martins-Costa MC, Maciel RMB, Kasamatsu TS, Nakabashi CCD, Camacho CP, Crispim F, Ikejiri ES, Mamone MCO, Andreoni DM, Biscolla RPM.

Arch Endocrinol Metab. 2017 Mar-Apr;61(2):108-114. doi: 10.1590/2359-3997000000241. Epub 2017 Feb 13.

15.

M918V RET mutation causes familial medullary thyroid carcinoma: study of 8 affected kindreds.

Martins-Costa MC, Cunha LL, Lindsey SC, Camacho CP, Dotto RP, Furuzawa GK, Sousa MS, Kasamatsu TS, Kunii IS, Martins MM, Machado AL, Martins JR, Dias-da-Silva MR, Maciel RM.

Endocr Relat Cancer. 2016 Dec;23(12):909-920.

PMID:
27807060
16.

Correlation between indoleamine 2,3 dioxygenase mRNA and CDKN2A/p16 mRNA: a combined strategy to cervical cancer diagnosis.

Saffi Junior MC, Duarte ID, Brito RB, Prado GG, Makabe S, Dellê H, Camacho CP.

Med Oncol. 2016 Nov;33(11):132. Epub 2016 Oct 19.

PMID:
27761872
17.

A Prospective Study Showing an Excellent Response of Patients with Low-Risk Differentiated Thyroid Cancer Who Did Not Undergo Radioiodine Remnant Ablation after Total Thyroidectomy.

Janovsky CC, Maciel RM, Camacho CP, Padovani RP, Nakabashi CC, Yang JH, Malouf EZ, Ikejiri ES, Mamone MC, Wagner J, Andreoni DM, Biscolla RP.

Eur Thyroid J. 2016 Mar;5(1):44-9. doi: 10.1159/000442048. Epub 2015 Nov 24.

18.

Analysis of somatic mutations in BRAF, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma.

Nascimento FP, Cardoso MG, Lindsey SC, Kunii IS, Valente FO, Kizys MM, Delcelo R, Camacho CP, Maciel RM, Dias-Da-Silva MR.

Mol Med Rep. 2016 Feb;13(2):1653-60. doi: 10.3892/mmr.2015.4731. Epub 2015 Dec 29.

PMID:
26718898
19.

Macrocalcitonin Is a Novel Pitfall in the Routine of Serum Calcitonin Immunoassay.

Alves TG, Kasamatsu TS, Yang JH, Meneghetti MC, Mendes A, Kunii IS, Lindsey SC, Camacho CP, Dias da Silva MR, Maciel RM, Vieira JG, Martins JR.

J Clin Endocrinol Metab. 2016 Feb;101(2):653-8. doi: 10.1210/jc.2015-3137. Epub 2015 Dec 8.

PMID:
26647152
20.

Assessment of the Effect of Two Distinct Restricted Iodine Diet Durations on Urinary Iodine Levels (Collected over 24 h or as a Single-Spot Urinary Sample) and Na(+)/I(-) Symporter Expression.

Padovani RP, Maciel RM, Kasamatsu TS, Freitas BC, Marone MM, Camacho CP, Biscolla RP.

Eur Thyroid J. 2015 Jun;4(2):99-105. doi: 10.1159/000433426. Epub 2015 Jun 11.

21.

Antimicrobial photodynamic therapy combined with periodontal treatment for metabolic control in patients with type 2 diabetes mellitus: study protocol for a randomized controlled trial.

Evangelista EE, França CM, Veni P, de Oliveira Silva T, Gonçalves RM, de Carvalho VF, Deana AM, Fernandes KP, Mesquita-Ferrari RA, Camacho CP, Bussadori SK, Alvarenga LH, Prates RA.

Trials. 2015 May 27;16:229. doi: 10.1186/s13063-015-0757-3.

22.

Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility.

Toledo RA, Hatakana R, Lourenço DM Jr, Lindsey SC, Camacho CP, Almeida M, Lima JV Jr, Sekiya T, Garralda E, Naslavsky MS, Yamamoto GL, Lazar M, Meirelles O, Sobreira TJ, Lebrao ML, Duarte YA, Blangero J, Zatz M, Cerutti JM, Maciel RM, Toledo SP.

Endocr Relat Cancer. 2015 Feb;22(1):65-76. doi: 10.1530/ERC-14-0491. Epub 2014 Nov 25.

23.

Integration of a postoperative calcitonin measurement into an anatomical staging system improves initial risk stratification in medullary thyroid cancer.

Yang JH, Lindsey SC, Camacho CP, Valente FO, Germano-Neto F, Machado AL, Mamone MC, Brodskyn F, Biscolla RP, Tuttle RM, Dias-da-Silva MR, Maciel RM.

Clin Endocrinol (Oxf). 2015 Dec;83(6):938-42. doi: 10.1111/cen.12657. Epub 2014 Dec 19.

PMID:
25376110
24.

Development and application of a novel sensitive immunometric assay for calcitonin in a large cohort of patients with medullary and differentiated thyroid cancer, thyroid nodules, and autoimmune thyroid diseases.

Camacho CP, Lindsey SC, Kasamatsu TS, Machado AL, Martins JR, Biscolla RP, Dias da Silva MR, Vieira JG, Maciel RM.

Eur Thyroid J. 2014 Jun;3(2):117-24. doi: 10.1159/000363055. Epub 2014 Jun 18.

25.

Basal serum thyroglobulin measured by a second-generation assay is equivalent to stimulated thyroglobulin in identifying metastases in patients with differentiated thyroid cancer with low or intermediate risk of recurrence.

Nakabashi CC, Kasamatsu TS, Crispim F, Yamazaki CA, Camacho CP, Andreoni DM, Padovani RP, Ikejiri ES, Mamone MC, Aldighieri FC, Wagner J, Hidal JT, Vieira JG, Biscolla RP, Maciel RM.

Eur Thyroid J. 2014 Mar;3(1):43-50. doi: 10.1159/000360077. Epub 2014 Mar 12.

26.

A ten-year clinical update of a large RET p.Gly533Cys kindred with medullary thyroid carcinoma emphasizes the need for an individualized assessment of affected relatives.

Signorini PS, França MI, Camacho CP, Lindsey SC, Valente FO, Kasamatsu TS, Machado AL, Salim CP, Delcelo R, Hoff AO, Cerutti JM, Dias-da-Silva MR, Maciel RM.

Clin Endocrinol (Oxf). 2014 Feb;80(2):235-45. doi: 10.1111/cen.12264. Epub 2013 Jun 28.

PMID:
23745650
27.

Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families.

Valente FO, Dias da Silva MR, Camacho CP, Kunii IS, Bastos AU, da Fonseca CC, Simião HP, Tamanaha R, Maciel RM, Cerutti JM.

J Endocrinol Invest. 2013 Dec;36(11):975-81. doi: 10.3275/8997. Epub 2013 May 30.

PMID:
23723040
28.

Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests.

Camacho CP, Lindsey SC, Melo MC, Yang JH, Germano-Neto F, Valente Fde O, Lima TR, Biscolla RP, Vieira JG, Cerutti JM, Dias-da-Silva MR, Maciel RM.

Thyroid. 2013 Mar;23(3):308-16. doi: 10.1089/thy.2012.0361.

29.

One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy.

Padovani RP, Kasamatsu TS, Nakabashi CC, Camacho CP, Andreoni DM, Malouf EZ, Marone MM, Maciel RM, Biscolla RP.

Thyroid. 2012 Sep;22(9):926-30. doi: 10.1089/thy.2012.0099. Epub 2012 Jul 24.

30.

Extended RET gene analysis in patients with apparently sporadic medullary thyroid cancer: clinical benefits and cost.

Lindsey SC, Kunii IS, Germano-Neto F, Sittoni MY, Camacho CP, Valente FO, Yang JH, Signorini PS, Delcelo R, Cerutti JM, Maciel RM, Dias-da-Silva MR.

Horm Cancer. 2012 Aug;3(4):181-6. doi: 10.1007/s12672-012-0109-7. Epub 2012 May 31.

PMID:
22648435
31.

The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.

Oliveira MN, Hemerly JP, Bastos AU, Tamanaha R, Latini FR, Camacho CP, Impellizzeri A, Maciel RM, Cerutti JM.

Thyroid. 2011 Sep;21(9):975-85. doi: 10.1089/thy.2010.0190. Epub 2011 Aug 11.

PMID:
21834681
32.

[Evaluation of clinical, laboratorial and ultrasonographic predicting factors of malignancy in thyroid nodules].

Rio AL, Biscolla RP, Andreoni DM, Camacho CP, Nakabashi CC, Mamone Mda C, Ikejiri ES, Matsumura LK, Hidal JT, Maciel RM, Furlanetto RP.

Arq Bras Endocrinol Metabol. 2011 Feb;55(1):29-37. Portuguese.

PMID:
21468517
33.

Development of a sensitive and specific quantitative reverse transcription-polymerase chain reaction assay for blood thyroglobulin messenger ribonucleic acid in the follow-up of patients with differentiated thyroid carcinoma.

Boldarine VT, Maciel RM, Guimarães GS, Nakabashi CC, Camacho CP, Andreoni DM, Mamone Mda C, Ikejiri ES, Kasamatsu TS, Crispim F, Hojaij FC, Hidal JT, Biscolla RP.

J Clin Endocrinol Metab. 2010 Apr;95(4):1726-33. doi: 10.1210/jc.2009-1354. Epub 2010 Feb 19.

PMID:
20173019
34.

Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians.

Camacho CP, Hoff AO, Lindsey SC, Signorini PS, Valente FO, Oliveira MN, Kunii IS, Biscolla RP, Cerutti JM, Maciel RM.

Arq Bras Endocrinol Metabol. 2008 Nov;52(8):1393-8.

PMID:
19169500
35.

Evaluation of RET polymorphisms in a six-generation family with G533C RET mutation: specific RET variants may modulate age at onset and clinical presentation.

Tamanaha R, Camacho CP, Pereira AC, da Silva AM, Maciel RM, Cerutti JM.

Clin Endocrinol (Oxf). 2009 Jul;71(1):56-64. doi: 10.1111/j.1365-2265.2008.03491.x. Epub 2008 Dec 5.

PMID:
19138318
36.

Clinical and molecular analysis of thyroid hypoplasia: a population-based approach in southern Brazil.

Ramos HE, Nesi-França S, Boldarine VT, Pereira RM, Chiamolera MI, Camacho CP, Graf H, de Lacerda L, Carvalho GA, Maciel RM.

Thyroid. 2009 Jan;19(1):61-8. doi: 10.1089/thy.2008.0116.

PMID:
18976153
37.

Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment.

Camacho CP, Latini FR, Oler G, Hojaij FC, Maciel RM, Riggins GJ, Cerutti JM.

Clin Endocrinol (Oxf). 2009 Mar;70(3):475-83. doi: 10.1111/j.1365-2265.2008.03349.x. Epub 2008 Aug 22.

38.

Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis.

Oler G, Camacho CP, Hojaij FC, Michaluart P Jr, Riggins GJ, Cerutti JM.

Clin Cancer Res. 2008 Aug 1;14(15):4735-42. doi: 10.1158/1078-0432.CCR-07-4372.

39.

Management of Graves' orbitopathy in Latin America: an international questionnaire study compared with Europe.

Ramos HE, Diehl LA, Camacho CP, Perros P, Graf H; Latin American Thyroid Society.

Clin Endocrinol (Oxf). 2008 Dec;69(6):951-6. doi: 10.1111/j.1365-2265.2008.03289.x. Epub 2008 Apr 29.

PMID:
18462263
40.

Y791F RET mutation and early onset of medullary thyroid carcinoma in a Brazilian kindred: evaluation of phenotype-modifying effect of germline variants.

Tamanaha R, Camacho CP, Ikejiri ES, Maciel RM, Cerutti JM.

Clin Endocrinol (Oxf). 2007 Nov;67(5):806-8. Epub 2007 Jul 4. No abstract available.

PMID:
17610518
41.

[Diagnosis of metastases in patients with papillary thyroid cancer by the measurement of thyroglobulin in fine needle aspirate].

Biscolla RP, Ikejiri ES, Mamone MC, Nakabashi CC, Andrade VP, Kasamatsu TS, Crispim F, Chiamolera MI, Andreoni DM, Camacho CP, Hojaij FC, Vieira JG, Furlanetto RP, Maciel RM.

Arq Bras Endocrinol Metabol. 2007 Apr;51(3):419-25. Portuguese.

PMID:
17546240
42.

Identification of candidates for tumor-specific alternative splicing in the thyroid.

Guimarães GS, Latini FR, Camacho CP, Maciel RM, Dias-Neto E, Cerutti JM.

Genes Chromosomes Cancer. 2006 Jun;45(6):540-53.

PMID:
16493598

Supplemental Content

Loading ...
Support Center